[The influence of CYP2C9 genetic polymorphism on the pharmacokinetics and pharmacodynamics of warfarin in patients with constant atrial fibrillation].

Source:http://linkedlifedata.com/resource/pubmed/id/17419358

Download in:

View as

General Info

PMID
17419358